Amanda Gibbon

Royal Free London NHS Foundation Trust operates hospitals and clinics. The company was founded on July 1, 2014 and is headquartered in London, the United Kingdom.

University College London Hospitals NHS Foundation Trust provides first-class acute and specialist services in six hospitals in central London, UK. The British company's mission is to deliver top-quality patient care, excellent education, and world-class research. The private company also offers events, classes, and workshops at the Macmillan Support and Information Service (MSIS) and an audiological service for GPs who would like to refer patients for age-related audiological assessments. Additionally, the company provides information about the sarcoma service and hearing therapists who work with adults who have hearing loss and associated disorders, such as tinnitus and hyperacusis, and other forms of hypersensitivity. The company is ultimately controlled by the Government of United Kingdom.

Rarecan Ltd. is a patient-centric research platform that provides clinical trial recruitment and retention services. The company is based in Hexham, UK. The British company supports and augments recruitment through sites and existing site-to-site referral networks, and provides a patient concierge service through which patients can be actively supported during screening, enrollment, and throughout their participation. Rarecan helps patients with rare histological cancers to identify potentially suitable clinical trials. The CEO of the company is Piers Kotting.